Tickets are available – and registration will be open right up until the day of the event – for the 2024 Protein Science in Drug Discovery conference at Hinxton Hall on 18 and 19 November.
Hosted by ELRIG and The Protein Society, the interactive event will include four sessions as leading scientists from industry and academia focus on the application of emerging areas of protein science to the challenges of modern drug discovery.
They will discuss high-throughput methods for protein expression, approaches for generation of antigens for antibody and vaccine discovery, analytical techniques to interrogate protein quality, and the application of cryogenic electron microscopy (cryo-EM) for druggability, as well as sequence-based predictive methods.
The conference, which is free to attend, will also includes poster presentations, networking sessions as well as a vendor exhibition, and offers travel bursary opportunities for early career professionals.
Melanie Leveridge, chair of ELRIG UK, and vice president of discovery biology of AstraZeneca, said: “Our organisations share a unifying goal — to provide a platform that enables academia and industry to exchange knowledge that supports innovation and fosters collaboration across the life science community. So, we are delighted to join forces with the renowned Protein Society to deliver this year’s Protein Sciences in Drug Discovery event.”
Prof Elizabeth Meiering, president of The Protein Society, and Professor at University of Waterloo, said: “We are excited to launch this unique interdisciplinary event in partnership with ELRIG. Bringing together leading experts from complementary disciplines provides an exceptional opportunity to communicate the latest advances and techniques in protein science and how to apply them to support drug discovery. We look forward to connecting our community with its global drug discovery network.”
Visit shorturl.at/2Ruio for free registration.
This post was originally published on here
